Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-12

Clinical Trial Update: A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects [Phase 2]

View source ↗

Summary

Phase II trial comparing liquid-frozen and freeze-dried IMVAMUNE (MVA-BN) smallpox vaccine formulations in vaccinia-naïve healthy subjects; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IMVAMUNE (MVA-BN) (MVA-BN)

Snippet

Sponsor: Bavarian Nordic | Conditions: Smallpox | Phase 2 | Status: COMPLETED | Results posted: 2020-10-12